Professor McMurray is currently Professor of Medical Cardiology and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. Professor McMurray served as the inaugural Eugene Braunwald Scholar in Cardiovascular Disease at the Brigham and Women’s Hospital, Boston, and visiting Professor of Medicine, Harvard University, Boston, Massachusetts USA 2010/2011. He is a Past-President of the Heart Failure Association of the ESC. He is a Highly Cited Researcher and has a H-index of >200. He is and has been involved in many guideline committees, including chairing the Task Force for 2012 ESC Guidelines on heart failure and was a member of the 2016 and 2021 Task Forces. Professor McMurray is an Associate Editor for JACC-Heart Failure and is also a member of the editorial board of several journals including the European Journal of Heart Failure, Diabetes Care and the New England Journal of Medicine, and Guest Editor for Circulation & Circulation: Heart Failure. He is the Congress Programme Committee Chair for the European Society of Cardiology 2023/2024 and European Society of Cardiology Board Member. Professor McMurray was a member of the recent European Society of Cardiology (ESC) Task Force that created a policy on gender and the NEJM policy group on diversity in research studies. He has won several awards, including the Stokes Medal of the Irish Cardiac Society. In June 2015, Professor John McMurray and Professor Salim Yusuf (McMaster University, Hamilton Ontario, Canada) were jointly awarded the 8th Arrigo Recordati International Prize for Scientific Research (for outstanding contributions in secondary prevention and risk reduction strategies in patients with cardiovascular diseases). Professor McMurray is the recipient of the Mackenzie Medal, which is awarded by the British Cardiovascular Society in recognition of outstanding service to British Cardiology. He is also the recipient of the Louis and Artur Lucian Award for Research in Circulatory Diseases, which is awarded each year by McGill University, Montreal. This international award recognises outstanding research in the field of circulatory diseases by a scientific investigator, or group of investigators, whose contribution to knowledge in this field is deemed worthy of special recognition. Professor McMurray was awarded an (honorary) OBE in 2019 by Her Majesty the Queen, in recognition of his services to cardiovascular research. In 2020 he was awarded the Gold Medal of the European Society of Cardiology, which the society describes as “the highest honour it can bestow on exceptional scientists for their contribution to cardiovascular medicine”. In 2021 Professor McMurray received the Rigshospitalet’s International KFJ Award. In 2023 he was made an honorary fellow of the Japanese Circulation Society. Professor McMurray has been invited to lecture widely at many international congresses and delivered many several named lectures.

John Atherton (MBBS, PhD, FRACP, FCSANZ, FHFA) is a Pre-eminent Staff Specialist and Director of Cardiology at the Royal Brisbane and Women’s Hospital (RBWH) and Professor, Faculty of Medicine, University of Queensland. Professor Atherton was one of four non-European official content reviewers for the 2016 European Society of Cardiology Heart Failure Guidelines and is a European Society of Cardiology Heart Failure Association Ambassador. He chaired the 2018 National Heart Foundation of Australia/ Cardiac Society of Australia and New Zealand (CSANZ) Heart Failure Guidelines, sits on the Therapeutic Guidelines Cardiovascular Expert Group and co-authored the first universal definition of heart failure. Professor Atherton is Data Custodian for the Queensland Cardiac Outcomes Registry (QCOR)- Heart Failure and sits as a Director on the National Cardiac Registry Board. His clinical and research interests include investigating novel methods to detect pre-symptomatic heart disease, heart failure disease management, hypertrophic cardiomyopathy and cardiac genetics.

Dr. Jessup is the Chief Science and Medical Officer of the American Heart Association and an Emeritus Professor of Medicine at the University of Pennsylvania School of Medicine. She was the Chief Scientific Officer of the Leducq Foundation from January 2017 through August of 2018, before moving to the American Heart Association role. She practised heart failure and transplant cardiology for 30 years at the Hospital of the University of Pennsylvania, where she served in a variety of administrative roles, including Medical Chief of the Heart and Vascular program, and Clinical Chief of Cardiology. She has been a long-time volunteer of the AHA and was a member of the Board of Directors of the national AHA, and President from 2013-2014.

Dr Walter Abhayaratna is a consultant cardiologist, Clinical Director and Director of Research Operations and Clinical Trials, Canberra Health Services. His PhD at the Australian National University was in the field of cardiovascular epidemiology and echocardiography, and he is the Professor of Cardiovascular Medicine at the Australian National University.

David Muller is Professor of Medicine at the University of New South Wales, Director of Interventional Cardiology Services at St Vincent’s Hospital, Sydney, and a faculty member of the Victor Chang Cardiac Research Institute. After graduating from the University of Melbourne, he completed his Advanced Training in Cardiology in Melbourne and Interventional Cardiology Fellowship at the University of Michigan Medical Centre. His current major research interests include transcatheter therapies for structural heart disease, the physiological and haemodynamic responses to transcatheter valve interventions, and optimizing the outcomes of complex coronary interventions. He has published widely (>500 peer reviewed papers, abstracts and book chapters) and is a regular speaker at international Cardiology meetings. He has held leadership roles in multiple international device trials, including first-in-human studies, and has been a member of numerous state and federal government Advisory Committees.

Professor Andrew Sindone has been involved in cardiac research, teaching and improving the lives of those living with cardiovascular disease for almost thirty years. He set up and continues to run the Heart Failure Unit at Concord Hospital with the Heart Failure Clinic, research, rehabilitation and outreach programs. He is involved in teaching medical students, junior doctors, General Practitioners and specialists, and ran a program to update specialists in the management of heart failure over a ten year period. Professor Sindone has received multiple awards and has been Principal Investigator in over 40 international multicentre clinical trials, has presented over 85 research papers and continues to publish in cardiovascular disease. He is a Co-chairman of the NSW Cardiovascular Expert Reference Group, member of the Heart Foundation of Australia, was on the Scientific Committee for the World Congress of Cardiology in 2002 and is co-author of the Australian Guidelines for the Management of Heart Failure. He is patron of multiple charities and assists the Italian Community in education and support of those with heart disease.